Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemidesmosome proteins are not a single target or molecule but refer collectively to a group of multiprotein complexes critical for cell-extracellular matrix adhesion, especially in epithelial tissues[1][2][3][5][6]. Their key components include integrin α6β4, plectin, BP180 (collagen XVII), BP230, and the tetraspanin CD151, which together form anchor points linking the basal keratin cytoskeleton to the basement membrane[1][2][3][5][6]. These proteins are essential for tissue resilience, mechanical stability, and integrity of epithelial layers, and disruptions can lead to severe blistering diseases and contribute to tumor progression and invasion[3][4][5][6]. The entry as "Hemidesmosomal and Extracellular Matrix Proteins" is overly broad and refers to a functional class rather than a specific target; thus, it is not suitable as a canonical drug target. Note: - The provided name is not a specific molecule or receptor, but a descriptive phrase for a class of structural and matrix proteins. There is no single target with this name. - Proper categorization would require specifying individual proteins, such as "Integrin α6β4" or "Plectin."[1][3][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemidesmosome protein.